SIRT2 as a therapeutic target for age-related disorders

Frontiers in Pharmacology

Volumn 3 MAY, Issue , 2012, Pages

  de Oliveira, Rita Machado ^a   Sarkander, Jana ^a   Kazantsev, Aleksey G ^b   Outeiro, Tiago Fleming ^a,c,d  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Aging; Cancer; Metabolic syndrome; Neurodegenerative disorder; SIRT2

Indexed keywords

ALPHA SYNUCLEIN; AUTOPHAGY PROTEIN 5; CYTOPLASM PROTEIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE 1; PROTEOLIPID PROTEIN; SILENT INFORMATION REGULATOR PROTEIN 2; SIRTUIN 1; SIRTUIN 2; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; UNCLASSIFIED DRUG;

ADIPOCYTE; AGING; ARTICLE; AUTOPHAGY; BIOLOGICAL ACTIVITY; CALORIC RESTRICTION; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM DISEASE; CHROMATIN CONDENSATION; DEGENERATIVE DISEASE; DIABETES MELLITUS; G2 PHASE CELL CYCLE CHECKPOINT; GENE DELETION; GERIATRIC DISORDER; GLIOMA; GLUCONEOGENESIS; HEALTH CARE COST; HUMAN; LIFE EXPECTANCY; LIFE EXTENSION; MELANOMA; METABOLIC SYNDROME X; MYELINATION; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN MODIFICATION; PROTEIN TARGETING; REGULATORY MECHANISM; SIRT GENE; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 84866013044     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2012.00082     Document Type: Article

References (91)

1. Alim, M. A., Ma, Q. L., Takeda, K., Aizawa, T., Matsubara, M., Nakamura, M., Asada, A., Saito, T., Kaji, H., Yoshii, M., Hisanaga, S., and Ueda, K. (2004). Demonstration of a role for alpha-synuclein as a functional microtubule-associated protein. J. Alzheimers Dis. 6, 435-442; discussion 443-439.
2. Bae, N. S., Swanson, M. J., Vassilev, A., and Howard, B. H. (2004). Human histone deacetylase SIRT2 interacts with the homeobox transcription factor HOXA10. J. Biochem. 135, 695-700.
3. Bates, G. (2003). Huntingtin aggregation and toxicity in Huntington's disease. Lancet 361, 1642-1644.
4. Beirowski, B., Gustin, J., Armour, S. M., Yamamoto, H., Viader, A., North, B. J., Michan, S., Baloh, R. H., Golden, J. P., Schmidt, R. E., Sinclair, D. A., Auwerx, J., and Milbrandt, J. (2011). Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signaling. Proc. Natl. Acad. Sci. U.S.A. 108, E952-E961.
5. Black, J. C., Mosley, A., Kitada, T., Washburn, M., and Carey, M. (2008). The SIRT2 deacetylase regulates autoacetylation of p300. Mol. Cell 32, 449-455.
6. Blander, G., and Guarente, L. (2004). The Sir2 family of protein deacetylases. Annu. Rev. Biochem. 73, 417-435.
7. Bosch-Presegue, L., and Vaquero, A.. (2011). The dual role of sirtuins in cancer. Genes Cancer 2, 648-662.
8. Burnett, C., Valentini, S., Cabreiro, F., Goss, M., Somogyvari, M., Piper, M. D., Hoddinott, M., Sutphin, G. L., Leko, V., Mcelwee, J. J., Vazquez-Manrique, R. P., Orfila, A. M., Ackerman, D., Au, C., Vinti, G., Riesen, M.,Howard,K.,Neri,C.,Bedalov,A., Kaeberlein, M., Soti, C., Partridge, L., and Gems, D. (2011). Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature 477, 482-485.
9. Calnan, D. R., and Brunet, A. (2008). The FoxO code. Oncogene 27, 2276-2288.
10. Chen, D., and Guarente, L. (2007). SIR2: a potential target for calorie restriction mimetics. Trends Mol. Med. 13, 64-71.
11. Chen, D., Steele, A. D., Lindquist, S., and Guarente, L. (2005). Increase in activity during calorie restriction requires Sirt1. Science 310, 1641.
12. Cohen, H. Y., Miller, C., Bitterman, K. J., Wall, N. R., Hekking, B., Kessler, B., Howitz, K. T., Gorospe, M., De Cabo, R., and Sinclair, D. A. (2004). Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305, 390-392.
13. Das, C., Lucia, M. S., Hansen, K. C., and Tyler, J. K. (2009). CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature 459, 113-117.
14. Di Giovanni, S., Knights, C. D., Rao, M., Yakovlev, A., Beers, J., Catania, J., Avantaggiati, M. L., and Faden, A. I. (2006). The tumor suppressor protein p53 is required for neurite outgrowth and axon regeneration. EMBO J. 25, 4084-4096.
15. Dryden, S. C., Nahhas, F. A., Nowak, J. E., Goustin, A. S., and Tainsky, M. A. (2003). Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol. Cell. Biol. 23, 3173-3185.
16. Ford, E., Voit, R., Liszt, G., Magin, C., Grummt, I., and Guarente, L. (2006). Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev. 20, 1075-1080.
17. Ford, E. S., Giles,W. H., and Dietz,W. H. (2002). Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287, 356-359.
18. Forman, M. S., Lee, V. M., and Trojanowski, J. Q. (2005). Nosology of Parkinson's disease: looking for the way out of a quagmire. Neuron 47, 479-482
19. Frye, R. A. (2000). Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 273, 793-798.
20. Gelb, D. J., Oliver, E., and Gilman, S. (1999). Diagnostic criteria for Parkinson disease. Arch. Neurol. 56, 33-39
21. Guarente, L. (2006). Sirtuins as potential targets for metabolic syndrome. Nature 444, 868-874
22. Haigis, M. C., and Guarente, L. P. (2006). Mammalian sirtuins emerging roles in physiology, aging, and calorie restriction. Genes Dev. 20, 2913-2921
23. Haigis, M. C., and Sinclair, D. A. (2010). Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol. 5, 253-295
24. Han, Y., Jin, Y. H., Kim, Y. J., Kang, B. Y., Choi, H. J., Kim, D. W., Yeo, C. Y., and Lee, K. Y. (2008). Acetylation of Sirt2 by p300 attenuates its deacetylase activity. Biochem. Biophys. Res. Commun. 375, 576-580
25. Harting, K., and Knoll, B. (2010). SIRT2-mediated protein deacetylation: An emerging key regulator in brain physiology and pathology. Eur. J. Cell Biol. 89, 262-269
26. Haslam, D. W., and James, W. P. (2005). Obesity. Lancet 366, 1197-1209
27. Hiratsuka, M., Inoue, T., Toda, T., Kimura, N., Shirayoshi, Y., Kamitani, H., Watanabe, T., Ohama, E., Tahimic, C. G., Kurimasa, A., and Oshimura, M. (2003). Proteomicsbased identification of differentially expressed genes in human gliomas: down-regulation of SIRT2 gene. Biochem. Biophys. Res. Commun. 309, 558-566
28. Imai, S., Armstrong, C. M., Kaeberlein, M., and Guarente, L. (2000). Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403, 795-800
29. Inoue, T., Hiratsuka, M., Osaki, M., and Oshimura, M. (2007). The molecular biology of mammalian SIRT proteins: SIRT2 in cell cycle regulation. Cell Cycle 6, 1011-1018
30. Iseki, E., Marui, W., Sawada, H., Ueda, K., and Kosaka, K. (2000). Accumulation of human alphasynuclein in different cytoskeletons in Lewy bodies in brains of dementia with Lewy bodies. Neurosci. Lett. 290, 41-44
31. Jiang, W., Wang, S., Xiao, M., Lin, Y., Zhou, L., Lei, Q., Xiong, Y., Guan, K. L., and Zhao, S. (2011). Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase. Mol. Cell 43, 33-44
32. Jin,Y. H., Kim,Y. J., Kim, D. W., Baek, K. H., Kang, B. Y., Yeo, C. Y., and Lee, K. Y. (2008). Sirt2 interacts with 14-3-3 beta/gamma and down-regulates the activity of p53. Biochem. Biophys. Res. Commun. 368, 690-695
33. Jing, E., Gesta, S., and Kahn, C. R. (2007). SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation. Cell Metab. 6, 105-114
34. Kaeberlein, M., Mcvey, M., and Guarente, L. (1999). The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 13, 2570-2580
35. Kim, H. S., Vassilopoulos, A., Wang, R. H., Lahusen, T., Xiao, Z., Xu, X., Li, C., Veenstra, T. D., Li, B., Yu, H., Ji, J., Wang, X. W., Park, S. H., Cha, Y. I., Gius, D., and Deng, C. X. (2011). SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity. Cancer Cell 20, 487-499
36. Kim, M. J., Ahn, K., Park, S. H., Kang, H. J., Jang, B. G., Oh, S. J., Oh, S. M., Jeong, Y. J., Heo, J. I., Suh, J. G., Lim, S. S., Ko, Y. J., Huh, S. O., Kim, S. C., Park, J. B., Kim, J., Kim, J. I., Jo, S. A., and Lee, J. Y. (2009). SIRT1 regulates tyrosine hydroxylase expression and differentiation of neuroblastoma cells via FOXO3a. FEBS Lett. 583, 1183-1188
37. Koubova, J., and Guarente, L. (2003). How does calorie restriction work? Genes Dev. 17, 313-321
38. Kraft, C., Peter, M., and Hofmann, K. (2010). Selective autophagy:ubiquitin-mediated recognition and beyond. Nat. Cell Biol. 12, 836-841.
39. Lamming, D. W., Latorre-Esteves, M., Medvedik, O., Wong, S. N., Tsang, F. A., Wang, C., Lin, S. J., and Sinclair, D. A. (2005). HST2 mediates SIR2-independent life-span extension by calorie restriction. Science 309, 1861-1864
40. Landry,J.,Sutton,A.,Tafrov,S. T.,Heller, R. C., Stebbins, J., Pillus, L., and Sternglanz, R. (2000). The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc. Natl. Acad. Sci. U.S.A. 97, 5807-5811.
41. Lee, I. H., Cao, L., Mostoslavsky, R., Lombard, D. B., Liu, J., Bruns, N. E., Tsokos, M., Alt, F. W., and Finkel, T. (2008). A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc. Natl. Acad. Sci. U.S.A. 105, 3374-3379
42. Lennerz, V., Fatho, M., Gentilini, C., Frye, R. A., Lifke, A., Ferel, D., Wolfel, C., Huber, C., and Wolfel, T. (2005). The response of autologous T cells to a human melanoma is dominated by mutated neoantigens. Proc. Natl. Acad. Sci. U.S.A. 102, 16013-16018
43. Li, W., Zhang, B., Tang, J., Cao, Q., Wu, Y., Wu, C., Guo, J., Ling, E. A., and Liang, F. (2007). Sirtuin 2, a mammalian homolog of yeast silent information regulator-2 longevity regulator, is an oligodendroglial protein that decelerates cell differentiation through deacetylating alphatubulin. J. Neurosci. 27, 2606-2616.
44. Li, Y., Matsumori, H., Nakayama, Y., Osaki, M., Kojima, H., Kurimasa, A., Ito, H., Mori, S., Katoh, M., Oshimura, M., and Inoue, T. (2011). SIRT2 down-regulation in HeLa can induce p53 accumulation via p38 MAPK activation-dependent p300 decrease, eventually leading to apoptosis. Genes Cells 16, 34-45
45. Lin, S. J., Ford, E., Haigis, M., Liszt, G., and Guarente, L. (2004). Calorie restriction extends yeast life span by lowering the level of NADH. Genes Dev. 18, 12-16
46. Liszt, G., Ford, E., Kurtev, M., and Guarente, L. (2005). Mouse Sir2 homolog SIRT6 is a nuclear ADPribosyltransferase. J. Biol. Chem. 280, 21313-21320
47. Luthi-Carter, R., Taylor, D. M., Pallos, J., Lambert, E., Amore, A., Parker, A., Moffitt, H., Smith, D. L., Runne, H., Gokce, O., Kuhn, A., Xiang, Z., Maxwell, M. M., Reeves, S. A., Bates, G. P., Neri, C., Thompson, L. M., Marsh, J. L., and Kazantsev, A. G. (2010). SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis. Proc. Natl. Acad. Sci. U.S.A. 107, 7927-7932
48. Mattson, M. P., and Magnus, T. (2006). Ageing and neuronal vulnerability. Nat. Rev. Neurosci. 7, 278-294
49. Maxwell, M. M., Tomkinson, E. M., Nobles, J.,Wizeman, J. W.,Amore,A. M., Quinti, L., Chopra, V., Hersch, S. M., and Kazantsev, A. G. (2011). The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS. Hum. Mol. Genet. 20, 3986-3996
50. Moller, D. E., and Kaufman, K. D. (2005). Metabolic syndrome: a clinical and molecular perspective. Annu. Rev. Med. 56, 45-62
51. Nahhas, F., Dryden, S. C., Abrams, J., and Tainsky, M. A. (2007). Mutations in SIRT2 deacetylase which regulate enzymatic activity but not its interaction with HDAC6 and tubulin. Mol. Cell. Biochem. 303, 221-230
52. Nakagawa, T., Lomb, D. J., Haigis, M. C., and Guarente, L. (2009). SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 137, 560-570
53. North, B. J., Marshall, B. L., Borra, M. T., Denu, J. M., and Verdin, E. (2003). The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol. Cell 11, 437-444
54. North, B. J., and Verdin, E. (2007a). Interphase nucleo-cytoplasmic shuttling and localization of SIRT2 during mitosis. PLoS ONE 2, e784. doi:10.1371/journal.pone.0000784
55. North, B. J., and Verdin, E. (2007b). Mitotic regulation of SIRT2 by cyclin-dependent kinase 1-dependent phosphorylation. J. Biol. Chem. 282, 19546-19555
56. Outeiro, T. F., Kontopoulos, E., Altmann, S. M., Kufareva, I., Strathearn, K. E., Amore, A. M., Volk, C. B., Maxwell, M. M., Rochet, J. C., Mclean, P. J., Young, A. B., Abagyan, R., Feany, M. B., Hyman, B. T., and Kazantsev, A. G. (2007). Sirtuin 2 inhibitors rescue alphasynuclein-mediated toxicity in models of Parkinson's disease. Science 317, 516-519
57. Pallos, J., Bodai, L., Lukacsovich, T., Purcell, J. M., Steffan, J. S., Thompson, L. M., and Marsh, J. L. (2008). Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease. Hum. Mol. Genet. 17, 3767-3775
58. Pandithage, R., Lilischkis, R., Harting, K., Wolf, A., Jedamzik, B., Luscher-Firzlaff, J., Vervoorts, J., Lasonder, E., Kremmer, E., Knoll, B., and Luscher, B. (2008). The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility. J. Cell Biol. 180, 915-929
59. Payton, J. E., Perrin, R. J., Clayton, D. F., and George, J. M. (2001). Protein-protein interactions of alpha-synuclein in brain homogenates and transfected cells. Brain Res. Mol. Brain Res. 95, 138-145
60. Perrod, S., Cockell, M. M., Laroche, T., Renauld, H., Ducrest, A. L., Bonnard, C., and Gasser, S. M. (2001). A cytosolic NAD-dependent deacetylase, Hst2p, can modulate nucleolar and telomeric silencing in yeast. EMBO J. 20, 197-209.
61. Peters, C. J., Rees, J. R., Hardwick, R. H., Hardwick, J. S.,Vowler, S. L., Ong, C. A., Zhang, C., Save, V., O'Donovan, M., Rassl, D., Alderson, D., Caldas, C., and Fitzgerald, R. C. (2010). A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia. Gastroenterology 139, 1995-2004 e1915
62. Rasheed, B. K., Wiltshire, R. N., Bigner, S. H., and Bigner, D. D. (1999). Molecular pathogenesis of malignant gliomas. Curr. Opin. Oncol. 11, 162-167
63. Renault, V. M., Rafalski, V. A., Morgan, A. A., Salih, D. A., Brett, J. O., Webb, A. E., Villeda, S. A., Thekkat, P. U., Guillerey, C., Denko, N. C., Palmer, T. D., Butte, A. J., and Brunet, A. (2009). FoxO3 regulates neural stem cell homeostasis. Cell Stem Cell 5, 527-539
64. Rogina, B., and Helfand, S. L. (2004). Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc. Natl. Acad. Sci. U.S.A. 101, 15998-16003
65. Rothgiesser, K. M., Erener, S., Waibel, S., Luscher, B., and Hottiger, M. O. (2010). SIRT2 regulates NF-kappaB dependent gene expression through deacetylation of p65 Lys310. J. Cell Sci. 123, 4251-4258
66. Salminen, A., and Kaarniranta, K. (2009). NF-kappaB signaling in the aging process. J. Clin. Immunol. 29, 397-405
67. Shi, T., Wang, F., Stieren, E., and Tong, Q. (2005). SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J. Biol. Chem. 280, 13560-13567
68. Sinclair, D. A., and Guarente, L. (1997). Extrachromosomal rDNA circles a cause of aging in yeast. Cell 91, 1033-1042
69. Smith, J. S., Brachmann, C. B., Celic, I., Kenna, M. A., Muhammad, S., Starai, V. J., Avalos, J. L., Escalante-Semerena, J. C., Grubmeyer, C.,Wolberger, C., and Boeke, J. D. (2000). A phylogenetically conserved NAD+dependent protein deacetylase activity in the Sir2 protein family. Proc. Natl. Acad. Sci. U.S.A. 97, 6658-6663
70. Southwood, C. M., Peppi, M., Dryden, S., Tainsky, M. A., and Gow, A. (2007). Microtubule deacetylases, SirT2 and HDAC6, in the nervous system. Neurochem. Res. 32, 187-195
71. Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R., and Goedert, M. (1997). Alphasynuclein in Lewy bodies. Nature 388, 839-840
72. Tang, B. L., and Chua, C. E. (2008). SIRT2, tubulin deacetylation, and oligodendroglia differentiation. Cell Motil. Cytoskeleton 65, 179-182
73. Tanner, K. G., Landry, J., Sternglanz, R., and Denu, J. M. (2000). Silent information regulator 2 family of NADdependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc. Natl. Acad. Sci. U.S.A. 97, 14178-14182
74. Tao, R., Coleman, M. C., Pennington, J. D., Ozden, O., Park, S. H., Jiang, H., Kim, H. S., Flynn, C. R., Hill, S., Hayes Mcdonald, W., Olivier, A. K., Spitz, D. R., and Gius, D. (2010). Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol. Cell 40, 893-904
75. Taylor, D. M., Balabadra, U., Xiang, Z., Woodman, B., Meade, S., Amore, A., Maxwell, M. M., Reeves, S., Bates, G. P., Luthi-Carter, R., Lowden, P. A., and Kazantsev,A. G. (2011).A brainpermeable small molecule reduces neuronal cholesterol by inhibiting activity of sirtuin 2 deacetylase. ACS Chem. Biol. 6, 540-546
76. Tedeschi,A.,and Di Giovanni,S. (2009). The non-apoptotic role of p53 in neuronal biology: enlightening the dark side of the moon. EMBO Rep. 10, 576-583
77. Tissenbaum, H. A., and Guarente, L. (2001). Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410, 227-230
78. Vaquero, A., Scher, M., Lee, D., Erdjument-Bromage, H., Tempst, P., and Reinberg, D. (2004). Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol. Cell 16, 93-105
79. Vaquero, A., Scher, M. B., Lee, D. H., Sutton, A., Cheng, H. L., Alt, F. W., Serrano, L., Sternglanz, R., and Reinberg, D. (2006). SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev. 20, 1256-1261
80. Viswanathan, M., and Guarente, L. (2011). Regulation of Caenorhabditis elegans lifespan by sir-2.1 transgenes. Nature 477, E1-E2
81. Vogelstein, B., and Kinzler, K. W. (2004). Cancer genes and the pathways they control. Nat. Med. 10, 789-799
82. von Deimling, A., Nagel, J., Bender, B., Lenartz, D., Schramm, J., Louis, D. N., and Wiestler, O. D. (1994). Deletion mapping of chromosome 19 in human gliomas. Int. J. Cancer 57, 676-680
83. Wang, F., Chan, C. H., Chen, K., Guan, X., Lin, H. K., and Tong, Q. (2012). Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation. Oncogene 31, 1546-1557
84. Wang, F., Nguyen, M., Qin, F. X., and Tong, Q. (2007). SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction. Aging Cell 6, 505-514
85. Wang, F., and Tong, Q. (2009). SIRT2 suppresses adipocyte differentiation by deacetylating FOXO1 and enhancing FOXO1's repressive interaction with PPARgamma. Mol. Biol. Cell 20, 801-808
86. Werner, H. B., Kuhlmann, K., Shen, S., Uecker, M., Schardt, A., Dimova, K., Orfaniotou, F., Dhaunchak, A., Brinkmann, B. G., Mobius, W., Guarente, L., Casaccia-Bonnefil, P., Jahn, O., and Nave, K. A. (2007). Proteolipid protein is required for transport of sirtuin 2 into CNS myelin. J. Neurosci. 27, 7717-7730
87. Wong, E., and Cuervo, A. M. (2010). Autophagygoneawryinneurodegenerative diseases. Nat. Neurosci. 13, 805-811.
88. Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., and Mayo, M. W. (2004). Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23, 2369-2380.
89. Zhao, Y., Wang, L., Yang, J., Zhang, P., Ma, K., Zhou, J., Liao, W., and Zhu, W. G. (2010a). Anti-neoplastic activity of the cytosolic FoxO1 results from autophagic cell death. Autophagy 6, 988-990.
90. Zhao, Y., Yang, J., Liao, W., Liu, X., Zhang, H., Wang, S., Wang, D., Feng, J., Yu, L., and Zhu, W. G. (2010b). Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nat. Cell Biol. 12, 665-675.
91. Zhu, H., Zhao, L., Wang, E., Dimova, N., Liu, G., Feng, Y., and Cambi, F. (2012). The QKI-PLP pathway controls SIRT2 abundance in CNS myelin. Glia 60, 69-82.